Cover Image

Warfarin therapy in patients with coronary heart disease and atrial fibrillation: drug interactions and genetic sensitivity to warfarin

Saved in:

Bibliographic Details
Date:	2020
Main Authors:	O. A. Panibratiuk, O. A. Yakovleva
Format:	Article
Language:	English
Published:	2020
Series:	The Ukrainian Biochemical Journal
Online Access:	http://jnas.nbuv.gov.ua/article/UJRN-0001347063
Tags:	Add Tag No Tags, Be the first to tag this record!
Journal Title:	Library portal of National Academy of Sciences of Ukraine \| LibNAS

Institution

Library portal of National Academy of Sciences of Ukraine | LibNAS

Similar Items

Antiplatelet and anticoagulant therapy in patients with non-valve atrial fibrillation
by: E. L. Dolgova, et al.
Published: (2014)

The complex fractionated activity zones as predictors of atrial fibrillation relapse in patients with permanent atrial fibrillation
by: A. V. Goriachyi
Published: (2019)

Atrial fibrillation and change of extracellular matrix
by: A. V. Goriachiy, et al.
Published: (2019)

The role of the matrix metalloproteinase–9 in an atrial fibrillation progress
by: A. I. Gozhenko, et al.
Published: (2017)

The efficacy of the use of mexidol in complex treatment of patients with dyscirculatory encephalopathy combined with atrial fibrillation
by: E. V. Kavulia
Published: (2013)

Impact on key areas of complex fractionated activity in patients with duration of persistent atrial fibrillation
by: Ju. I. Karpenko, et al.
Published: (2014)

Genetic aspects of coronary artery disease risk and the efficacy of antithrombotic therapy
by: O. E. Zaprovalnaja
Published: (2016)

Citicoline affects serum angiostatin and neurospecific protein levels in patients with atrial fibrillation and ischemic stroke
by: A. A. Tykhomyrov, et al.
Published: (2019)

Influence of atrial fibrillation progressing on the level of matrix metal proteinase-9
by: A. I. Gozhenko, et al.
Published: (2017)

Current aspects of coronary heart disease diagnosis and treatment
by: O. M. Korzh
Published: (2020)

Eole of integrated fractionated activity in supporting long-standing persistent atrial fibrillation
by: Ju. I. Karpenko, et al.
Published: (2014)

Influence of dry carbon dioxide baths and interference therapy on endothelial dysfunction in complex treatment of patients with ischemic heart disease and coronary syndrome Kh
by: E. O. Penina
Published: (2016)

Concomitant coronary heart disease as a factor in reducing the quality of life of patients with chronic pancreatitis
by: L. S. Babinets, et al.
Published: (2019)

Sanatorium rehabilitation of patients with coronary heart disease after surgical myocardial revascularization conjunction with osteoarthritis
by: K. D. Babov, et al.
Published: (2015)

Study of asymmetric dimethylarginine level in patients with ischemic heart disease without coronary atherosclerotic lesion
by: D. M. Sebov, et al.
Published: (2015)

Formation, assessment and correction of cognitive disorders in patients with comorbid chronic obstructive pulmonary and coronary heart diseases
by: H. S. Isaieva, et al.
Published: (2021)

Preoperative verification of comorbidity in patients with high-risk coronary heart disease on the eve of surgical myocardial revascularization
by: O. K. Hohaieva
Published: (2021)

C-reactive protein level after catheter ablation of atrial fibrillation and its association with relapse
by: A. Y. Hozhenko, et al.
Published: (2017)

Efficiency of hypohomocystinemic therapy in patients with acute coronary syndrome
by: L. N. Prystupa, et al.
Published: (2015)

Prediction of the development of chronic coronary heart disease in patients with metabolic syndrome at obesity considered age and gender features
by: N. Chmyr
Published: (2018)

Clinical instrumental and genetic factors affecting the long-term prognosis in patients with coronary artery disease who underwent coronary artery stenting
by: V. J. Tselujko, et al.
Published: (2013)

Features of left ventricular remodeling in patients with coronary artery disease and metabolic syndrome after percutaneous coronary intervention for acute coronary syndrome without ST-segment elevation on the background of cardioprotective therapy
by: L. S. Kholopov, et al.
Published: (2016)

Comparative evaluation of cardio-hemodynamic characteristics in patients with coronary artery disease and coronary syndrome x
by: D. M. Sebov
Published: (2015)

Concentration of kidney function in patients with impaired left ventri¬cu¬lar systolic function in the back¬ground of coronary heart disease and hypertension
by: A. I. Hozhenko, et al.
Published: (2015)

Liver function in patients with coronary artery disease and nonalcoholic fatty liver disease associated with obesity
by: O. Bondarenko, et al.
Published: (2017)

Pathogenetic aspects of early cardiometabolic therapy in patients with acute coronary syndrome with no-st segment elevation after percutaneus coronary intervention
by: O. O. Jakimenko, et al.
Published: (2015)

Dynamics of clinical and functional indexes of cardiorespiratory system at the use of nicorandil in the treatment of patients with bronchial asthma in combination with coronary heart disease I-II FS
by: N. A. Matsehora, et al.
Published: (2017)

Supplement of standard therapy in patients with acute myocardial infarction after percutaneous coronary intervention
by: N. N. Dolog
Published: (2018)

The influence of antioxidant therapy on lipid peroxidation and antioxidant protection in ischemic heart disease
by: E. A. Pavlova
Published: (2017)

Analysis of genetic factors in patients with chronic heart failure
by: T. V. Martynovich, et al.
Published: (2014)

Correction of haemodynamic data in advanced age patients with primary hypertension combined with coronary heart disease depending on left ventricle hypertrophy presence, obesity and multiple comorbidity
by: N. V. Tofan
Published: (2015)

Survival predictors in elderly patients with chronic ischemic heart disease
by: A. L. Filipiuk, et al.
Published: (2012)

Cardiac safety of different variants of total intravenous anesthesia in patients with coronary artery disease
by: E. A. Karpenko
Published: (2014)

Pharmacogenomics of antiretroviral drugs, genetic therapy against HIV infection and genome edition
by: M. M. Shegaj, et al.
Published: (2016)

The use of alpha-lipoic acid in patients with chronic acalculous cholecystitis in combination with coronary artery disease
by: K. N. Kompaniets
Published: (2016)

Descamed endotheliocytes and stages of their dergradation in blood in patients with iscemic heart disease
by: A. E. Pavlega, et al.
Published: (2020)

The influence of eplerenone therapy on the processes of heart remodeling in patients after valve replacement.
by: A. V. Zhadan
Published: (2018)

Cell therapy of heart pathologies
by: Lukash, L.L.
Published: (2008)

Modeling of Production Industrial Process of the Drug Flocalin and Search of its Optimally Effective Dose for Treatment of Heart Diseases
by: R. B. Strutynskyi, et al.
Published: (2013)

Influence of metformin in comparison with influences of weight changes on prognosis and metabolic state of patients with coronary artery disease and prediabetes
by: Ya. Koroliuk, et al.
Published: (2012)